Form D · Biotechnology

MICROPHARMA LTD

Montreal, A8 · CIK 0001425232

Offering snapshot reported Jan 24, 2013 · SEC filing

Reported sold
$851K
Offering amount: $851K
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 9, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 24, 2013Initial$851,242No comparison9SEC filing
Jan 8, 2009PaperNot reportedNo comparisonNot reportedSEC filing
Dec 30, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jan 25, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired, Other
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-190721
Secured convertible debentures, together with underlying Class A common shares.

Source: Form D, filed Jan 24, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Borys Chabursky Director
Jeffrey Greenberg Director
Gordon Hammond Director
Mitchell Lawrence Jones Executive
Ryan Jones Executive
Mathieu Lhomme Director
Cuypers Maurits Director
Satya Prakash Director
Robert Semmens Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
4200 Saint Laurent Boulevard 4 Th Floor, Unit 409
Montreal, A8, H2W 2R2